[Current trends in head and neck squamous cell carcinomas].
Squamous cell carcinomas of the head and neck remain frequent in France with an evolving epidemiology. Progress was observed both in diagnostic and treatments. Increasing possibilities of curative treatment should be provided within next years through surgery, radiotherapy, chemotherapy and target therapies as well as high performance imaging modalities and molecular biology and tumoral markers. Surgical techniques have improved function preservation while non surgical means have increased efficacy through chemo-radiotherapy. Assessment of optimal sequential therapeutic strategies is required, including both oncologic efficacy and quality of life.
Lacau Saint-Guily
Jean
J
Service d'ORL et chirurgie cervicofaciale, hôpital Tenon, Université Paris 6, Pierre et Marie Curie, 4 rue de la Chine, 75020 Paris. jean.lacau@tnn.ap-hop-paris.fr
Périé
Sophie
S
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005602:France / Q000453:epidemiology; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D015994:Incidence; D007825:Laryngectomy; D020360:Neoadjuvant Therapy; D011379:Prognosis; D011788:Quality of Life